Last updated on August 2019

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease


Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.